Pediatr Surg Int
. 2022 Mar 2. doi: 10.1007/s00383-022-05096-0. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/35235015/
Tenascin C is dysregulated in hypoplastic lungs of miR-200b -/- mice
Moritz Markel 1 2, Wai Hei Tse 1, Nolan DeLeon 1, Daywin Patel 1, Shana Kahnamouizadeh 1, Martin Lacher 2, Richard Wagner 2, Richard Keijzer 3Affiliations expand
- PMID: 35235015
- DOI: 10.1007/s00383-022-05096-0
Abstract
Purpose: We previously demonstrated that absence of miR-200b results in abnormal lung development in congenital diaphragmatic hernia due to imbalance between epithelial and mesenchymal cells. Tenascin C is a highly conserved extracellular matrix protein involved in epithelial to mesenchymal transition, tissue regeneration and lung development. Considering the involvement of Tenascin C and miR-200b and their potential interaction, we aimed to study Tenascin C during lung development in the absence of miR-200b.
Methods: We collected lungs of miR-200b-/- mice (male, 8 weeks). We performed Western blot (WB) analysis (N = 6) and immunofluorescence (N = 5) for Tenascin C and alpha smooth muscle actin and RT-qPCR for Tenascin C gene expression (N = 4).
Results: Using WB analysis, we observed a decreased total protein abundance of Tenascin C in miR-200b-/- lungs (miR-200b+/+: 3.8 × 107 ± 1 × 107; miR-200b-/-: 1.9 × 107 ± 5 × 106; p = 0.002). Immunofluorescence confirmed decreased total Tenascin C in miR-200b-/- lungs. Tenascin C was significantly decreased in the mesenchyme but relatively increased in the airways of mutant lungs. Total lung RNA expression of Tenascin C was higher in miR-200b-/- lungs.
Conclusion: We report dysregulation of Tenascin C in lungs of miR-200b-/- mice. This suggests that absence of miR-200b results in abnormal Tenascin C abundance contributing to the lung hypoplasia observed in miR-200b-/- mice.
Keywords: Congenital diaphragmatic hernia; Pulmonary hypoplasia; Tenascin C; miR-200b.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.